Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib
Work
Year: 2006
Type: article
Source: Molecular Cancer Therapeutics
Institutions Cancer Research UK Scotland Institute, Cancer Research UK, Bristol-Myers Squibb (United States)
Cites: 60
Cited by: 122
Related to: 10
FWCI: 5.455
Citation percentile (by year/subfield): 90.59
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed